BREAKING
Jasper Therapeutics, Inc. (JSPR) Reports Q4 Earnings 10 minutes ago AEON Biopharma 2025 Financial Review 32 minutes ago Americas Gold and Silver Corporation (USAS) FY2025 Earnings: Misses on EPS, Revenue Recap 18 hours ago FormFactor, Inc. (FORM) Drops 6.1% to $92.00 18 hours ago Photronics, Inc. (PLAB) Drops 6.3% to $37.09 18 hours ago Amkor Technology, Inc. (AMKR) Drops 6.5% to $41.57 18 hours ago Teradyne, Inc. (TER) Drops 5.9% to $277.93 18 hours ago Lumentum Holdings Inc. (LITE) Drops 6.1% to $659.99 19 hours ago MP Materials Corp. (MP) Drops 8% to $47.53 19 hours ago Badger Meter, Inc. (BMI) Jumps 5.1% to $153.31 19 hours ago Jasper Therapeutics, Inc. (JSPR) Reports Q4 Earnings 10 minutes ago AEON Biopharma 2025 Financial Review 32 minutes ago Americas Gold and Silver Corporation (USAS) FY2025 Earnings: Misses on EPS, Revenue Recap 18 hours ago FormFactor, Inc. (FORM) Drops 6.1% to $92.00 18 hours ago Photronics, Inc. (PLAB) Drops 6.3% to $37.09 18 hours ago Amkor Technology, Inc. (AMKR) Drops 6.5% to $41.57 18 hours ago Teradyne, Inc. (TER) Drops 5.9% to $277.93 18 hours ago Lumentum Holdings Inc. (LITE) Drops 6.1% to $659.99 19 hours ago MP Materials Corp. (MP) Drops 8% to $47.53 19 hours ago Badger Meter, Inc. (BMI) Jumps 5.1% to $153.31 19 hours ago
ADVERTISEMENT
Breaking News

GPGI Shares Plunge 11.7% Despite EPS Beat as $216.7M Net Loss and Zero Revenue Alarm Investors

GPGI posts 10.7% EPS beat at $0.29 but shares crash 11.7% on zero revenue, $216.7M net loss, and negative $257.4M EBITDA.

March 9, 2026 2 min read
salesforce

GPGI posts 10.7% EPS beat at $0.29 but shares crash 11.7% on zero revenue, $216.7M net loss, and negative $257.4M EBITDA.

Earnings Per Share
$0.29
vs $0.26 est. (+10.7%)
Revenue
$120.9 Mn
estimate N/A

EPS beats, stock plunges. GPGI, Inc. reported Q3 2025 diluted EPS of $0.29, topping the consensus estimate of $0.26 by $0.03. The 10.7% surprise marks the third consecutive quarterly beat, yet shares tumbled 11.7% to $20.33 on volume of 3.5 million shares. The metal fabrication company posted a net loss of $216.7 million despite the positive EPS figure, signaling significant non-operating charges or adjustments that drove the headline number positive while underlying operations remained deeply unprofitable.

Revenue reported to be $120.9 Mn, profitability metrics alarming. The company reported revenue of $120.9 Mn for the quarter. Operating income of $9.1 million and gross profit of $81.3 million against cost of revenue of $79.4 million paint a confusing picture when reconciled with the $216.7 million net loss. EBITDA of negative $257.4 million underscores severe cash-burning operations. Operating cash flow turned negative at $11.9 million, matching free cash flow of negative $11.9 million, while the company maintains $127.4 million in cash and zero debt.

Balance sheet provides runway, but clarity needed. With total assets of $505.5 million and stockholders’ equity of $152.5 million, GPGI maintains a solvent balance sheet despite accumulated losses reflected in retained earnings of negative $494.4 million. Working capital of $73.6 million offers near-term liquidity, bolstered by a $134.5 million financing cash inflow during the quarter. The market cap of $5.9 billion appears disconnected from the operational reality of zero reported revenue and massive losses.

GPGI price_30d
What to Watch: The company’s earnings call and 10-Q filing will be critical to explain the zero revenue figure, the $216.7 million net loss, and the reconciliation between positive operating income and catastrophic EBITDA. Investors need clarity on whether this reflects a business model transition, accounting restatement, or data reporting error before the stock can stabilize.

This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.

ADVERTISEMENT
Tags: #GPGI